by editor | Sep 24, 2013 | Asides, Blog
IsoRay, Inc. (NYSE MKT: ISR) ISR is up 11.3% at the close. Here is what is moving the stock: IsoRay Announces World’s First Cesium-131 Seeded Mesh Treatment for Advanced Rectal Cancer They have an underwriting offering is mentioned in recent releases as well....
by editor | Sep 9, 2013 | Blog, Trade Alert
Shares for CUR are up sharply over recent days. Looking at the six month chart we can see this trend has been going on for some time: UP NEXT: A CLOSER LOOK AT THE COMPANY From the Neuralstrem website, here is a description of what they do: Neuralstem’s...
by editor | Sep 2, 2013 | Asides, Blog
ZELTIQ Aesthetics Inc. – NasdaqGS: ZLTQ If this Company can do what they say they can do, it will be priceless. “Selectively reducing stubborn fat that may not respond to diet or exercise” is roughly what they claim with ZELTIQ(R). Their financial press release of...
by editor | Sep 2, 2013 | Asides, Blog
Sinovac Biotech Ltd. – NasdaqGS: SVA Another 52 week stock. This one hit it on Friday at $5.20. They reported outstanding results in their press release of August 13th: (unaudited numbers) Second Quarter 2013 Financial Highlights (period-over-period comparisons to...
by editor | Sep 2, 2013 | Asides, Blog
PharmAthene Inc. – NYSE MKT: PIP This is another stock creating a new 52 week high just days ago. At $2.42 last week, you would have to go back to 2011 to see higher levels. Why? I think part of the reason for the recent surge is this article by Jeff Eiseman at...
